Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1558]

IGF2BP1: a critical driver of cancer progression and therapeutic target

IGF2BP1: a critical driver of cancer progression and therapeutic target

Epigenetic drivers of liver cancer: unraveling mechanisms behind hepatocellular carcinoma

Epigenetic drivers of liver cancer: unraveling mechanisms behind hepatocellular carcinoma

ImmunoPET tracer enhances early detection of liver cancer

ImmunoPET tracer enhances early detection of liver cancer

Researchers part of team developing imaging tool that could transform brain cancer surgery

Researchers part of team developing imaging tool that could transform brain cancer surgery

Circular RNAs open new frontiers in hepatitis B virus-induced liver cancer

Circular RNAs open new frontiers in hepatitis B virus-induced liver cancer

Pancreatic cancer vaccines eliminate disease in preclinical trials

Pancreatic cancer vaccines eliminate disease in preclinical trials

Removing a cancer-activated cell type has been shown to virtually eliminate liver metastasis

Removing a cancer-activated cell type has been shown to virtually eliminate liver metastasis

Pancreatic cancer spreads to liver or lung thanks to this protein

Pancreatic cancer spreads to liver or lung thanks to this protein

ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study...

ASCO 2025: Post-hoc analysis demonstrates patient characteristics associated with long-term overall survival with irinotecan liposome injection in metastatic pancreatic adenocarcinoma

ASCO 2025: Post-hoc analysis demonstrates patient characteristics associated with long-term overall survival with...

More from ecancer